SCHEMBL5380795

SCHEMBL5380795

COC(=O)c1cc(S(=O)(=O)Nc2ccc(SCc3ccc(F)c(F)c3)cc2)ccc1C

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.47
PABPC1 P11940 1/20 0.47
HTT P42858 3/20 0.46
NPSR1 Q6W5P4 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.45
CASP6 P55212 1/20 0.44
MAPT P10636 5/20 0.43
ALDH1A1 P00352 4/20 0.43
KDM4E B2RXH2 3/20 0.43
TSHR P16473 2/20 0.43
GAA P10253 1/20 0.43
ALOX15 P16050 1/20 0.43
MAPK1 P28482 1/20 0.42
METAP2 P50579 1/20 0.42
LMNA P02545 4/20 0.41
HSD17B10 Q99714 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
THRB P10828 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5373887 0.90 POLB (0.49) POLBPABPC1HTTNPSR1SMN1; SMN2
SCHEMBL5391181 0.90 POLB (0.54) POLBPABPC1HTTNPSR1SMN1; SMN2
SCHEMBL5376629 0.90 CASP6 (0.52) POLBPABPC1HTTNPSR1SMN1; SMN2
SCHEMBL5376596 0.88 POLB (0.49) POLBPABPC1HTTNPSR1SMN1; SMN2
SCHEMBL5382317 0.86 POLB (0.51) POLBPABPC1HTTNPSR1SMN1; SMN2
SCHEMBL5368231 0.86 PLAU (0.53) POLBPABPC1HTTNPSR1SMN1; SMN2
SCHEMBL5368417 0.86 ALOX15 (0.48) POLBPABPC1HTTNPSR1SMN1; SMN2
SCHEMBL5382518 0.86 POLB (0.47) POLBPABPC1HTTNPSR1SMN1; SMN2
SCHEMBL5378678 0.85 POLB (0.50) POLBPABPC1HTTNPSR1SMN1; SMN2
SCHEMBL5391352 0.84 POLB (0.47) POLBPABPC1HTTNPSR1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD POLB 1807/4885PABPC1 3612/4885HTT 696/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD POLB 2006/4885PABPC1 3461/4885HTT 894/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.